# A Prospective Randomized Trial Comparing Effectiveness of Parasagittal and Midline Epidural Steroid Injection in Patients with Lumbar Canal Stenosis Pain

**Authors:** Masoud Hashemi, Faranak Behnaz, Payman Dadkhah, Ali Alizadeh Ojoor, Sina Hassannasab, Seyed Sam Mehdi Hosseininasab, Sogol Asgari

PMC · DOI: 10.5812/aapm-157791 · Anesthesiology and Pain Medicine · 2025-02-16

## TL;DR

This study compares two injection methods for treating low back pain caused by spinal stenosis and finds one method more effective in reducing pain over time.

## Contribution

A prospective randomized trial comparing parasagittal and midline epidural steroid injection effectiveness in lumbar canal stenosis pain.

## Key findings

- PIL group showed significantly lower pain intensity at 3 months compared to the MIL group.
- PIL group had higher functional disability scores and lower patient satisfaction at 3 months.
- No significant differences were observed at baseline or 1-month follow-up.

## Abstract

Low back pain (LBP) due to lumbar spinal stenosis presents a significant clinical challenge. Epidural steroid injections (ESIs) are a common treatment option; however, the optimal injection route remains debated.

To compare the clinical outcomes of parasagittal interlaminar (PIL) versus midline interlaminar (MIL) ESI in patients with LBP attributed to lumbar spinal stenosis.

This prospective, randomized study included patients with LBP and lumbar stenosis. Participants were randomly assigned to receive ESI via either the PIL or MIL route. Clinical outcomes, including pain intensity (measured by the Numeric Rating Scale [NRS]) and functional disability (assessed using the Modified Oswestry Disability Index [MODQ]), were evaluated at 1- and 3-months post-injection.

Analysis revealed a significant reduction in pain intensity (NRS) at 3 months post-injection in the PIL group compared to the MIL group (P = 0.014). Additionally, the PIL group demonstrated significantly lower patient satisfaction scores at 3 months (P = 0.033) and higher MODQ scores at 3 months (P = 0.002) compared to the MIL group. No significant differences were observed between groups at baseline or at the 1-month follow-up for any of the assessed outcomes.

This study suggests potential differences in efficacy between parasagittal and midline interlaminar ESIs for lumbar stenosis pain. These findings underscore the need for further research to optimize treatment strategies and improve pain management for patients with this condition.

## Linked entities

- **Diseases:** lumbar spinal stenosis (MONDO:0005965)

## Full-text entities

- **Diseases:** Stenosis Pain (MESH:D010146), LBP (MESH:D017116), lumbar spinal stenosis (MESH:C563613)
- **Chemicals:** Steroid (MESH:D013256)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12125659/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12125659/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12125659/full.md

---
Source: https://tomesphere.com/paper/PMC12125659